Business
Premier Biomedical, Inc.’s CEO Discusses a Bright Future for His Company and All-Natural Solutions with Uptick Newswire’s Stock Day Podcast
Premier Biomedical, Inc.’s CEO Discusses a Bright Future for His Company and All-Natural Solutions with Uptick Newswire’s Stock Day Podcast.
About this update from Premier Biomedical Inc
[{"type":"text","content":"\nPHOENIX, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCQB: BIEI) (“Company”) is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases. and provide all-natural, 50-state-legal topical pain relief products. CEO and President, William A. Hartman, was welcomed back to Stock Day by Everett Jolly.\n Hartman started off by telling Jolly he had a lot to cover in this interview and got right to it. “We started out as an R & D company developing cures for PTSD, cancer, and a number of other serious diseases in an extracorporeal manner via the use of antibodies,” Hartman explained. “In January of 2017, we developed and began selling topical pain relief products featuring Hemp oil/CBD. We didn’t eliminate our R & D goals, rather, we needed the projected sales and revenue from the hemp oil/CBD business to finance potential future R&D efforts. What we have come to realize is that the hemp oil/CBD business is very attractive and offers tremendous growth potential for the near future, particularly as an alternative to dangerous and addictive opioid pain killers.” Hartman went on to say Premier Biomedical’s hemp oil/CBD products are leaders in the industry. He then turned the discussion to a recent attempted joint venture in Europe. He said Premier Biomedical, Inc. is still in negotiations with the target company; however, that company ended up selling a portion of their business assets to another company. Premier Biomedical, Inc. is now renegotiating terms of that venture as well as actively seeking potential alternative JV targets. Hartman then turned the conversation to potential Department of Defense sales and mentioned that their program efforts are still in progress. “Our sales team consists of ex-pharmacy people and ex-Purchasing people from the DOD. Our team of experts know all the DOD Purchasing people by their first names,” he said. “Our focus with the DOD as well as with all other governmental agencies is the opioid crisis. Premier Biomedical’s topical pain relief products are an effective alternative to dangerous and addictive pain pills, which are a major contributor to the 200 drug overdose deaths per day occurring in the USA. “Our sales team is also wor...